| Trade Names: | |
| Synonyms: | |
| Status: | Approved (2002) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 4Q52C550XK |
Pharmacology
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Lymphoma, Non-Hodgkin | 3 | D008228 | ClinicalTrials |
| Lymphoma, Large B-Cell, Diffuse | 3 | D016403 | ClinicalTrials |
| Lymphoma, Follicular | 3 | D008224 | ClinicalTrials |
| Lymphoma, Follicular | 3 | D008224 | ClinicalTrials |
| Leukemia | 2 | D007938 | ClinicalTrials |
| Multiple Myeloma | 2 | D009101 | ClinicalTrials |
| Lymphoma | 2 | D008223 | ClinicalTrials |
| Lymphoma, Mantle-Cell | 2 | D020522 | ClinicalTrials |
| Graft vs Host Disease | 2 | D006086 | ClinicalTrials |
| Hodgkin Disease | 1 | D006689 | ClinicalTrials |
| Burkitt Lymphoma | 1 | D002051 | ClinicalTrials |
| Waldenstrom Macroglobulinemia | 1 | D008258 | ClinicalTrials |
| Lymphoma, AIDS-Related | 1 | D016483 | ClinicalTrials |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | D054198 | ClinicalTrials |
| Lymphoma, B-Cell, Marginal Zone | 1 | D018442 | ClinicalTrials |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | D015451 | ClinicalTrials |
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 206181-63-7 |
| ChEMBL | CHEMBL1201606 |
| FDA SRS | 4Q52C550XK |
| Guide to Pharmacology | 6777 |
| PubChem | 74890578 |
CONTENTS